Stilwell McDavid 4
4 · Coherus BioSciences, Inc. · Filed Jun 15, 2023
Insider Transaction Report
Form 4
Stilwell McDavid
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-06-13+70,000→ 70,000 totalExercise: $5.44Exp: 2033-06-13→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]The underlying shares subject to the option vest and become exercisable as to 50% of the shares on each anniversary measured from June 13, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.